Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Impedimed

1999 FOUNDED
PUBLIC STATUS
71-80 EMPLOYEES
IPD STOCK SYMBOL
1 INVESTMENTS
$0.32 SHARE PRICE (As of Friday Closing)
Description

Manufacturer and seller of bioimpedance instruments. The company develops bioimpedance devices with a focus on clinical assessment and monitoring of the fluid status area.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Monitoring Equipment
Stock Exchange
ASX
Primary Office
  • Unit 1
  • 50 Parker Court
  • Pinkenba, Queensland 4008
  • Australia

+61 (07) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Impedimed’s full profile, request a free trial.

Impedimed Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.27 - $0.81 $120M $0.32 707K 378M

Impedimed Financials Summary

In Thousands,
USD
TTM
31-Mar-2018
FY 2017
30-Jun-2017
FY 2016
30-Jun-2016
FY 2015
30-Jun-2015
Enterprise Value 216,381 175,697 202,216 169,593
Revenue 4,345 4,218 4,048
EBITDA (20,831) (18,904) (12,282)
Net Income (20,777) (18,924) (12,365)
Total Assets 49,444 67,636 29,082
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Impedimed Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Impedimed‘s full profile, request access.

Request full access to PitchBook

Impedimed Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 00000 26-Oct-2015 000000000000000000 Surgical Devices 0000000 0000000
To view this company’s complete investment and acquisition history, request access »

Impedimed Executive Team (5)

Name Title Board
Seat
Contact
Info
Richard Carreon President, Managing Director & Chief Executive Officer
Phil Auckland Chief Financial Officer & Chief Operating Officer
Morten Vigeland Chief Financial Officer
Chris Bulger Director, Business Development

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Impedimed Board Members (2)

Name Representing Role Since Contact
Info
Cherrell Hirst Impedimed Chairman 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »